William Blair Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

William Blair Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $7.89 Million - $10.5 Million	-184,848 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $2.19 Million - $2.97 Million	-49,576 Reduced 21.15%	184,848 $11.1 Million
Q1 2018 May 14, 2018	SELL	$37.15 - $46.9 $753,141 - $950,803	-20,273 Reduced 7.96%	234,424 $10.7 Million
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $2.29 Million - $2.68 Million	62,961 Added 32.84%	254,697 $10.2 Million
Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $7.05 Million - $9.52 Million	191,736	191,736 $7.67 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on William Blair Investment Management, LLC with notifications on news.